{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental condition: 0h baseline vs 96h treatment","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0004_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"73234","direction":"down","inn_name":"","iupac_name":"(19<i>R</i>,25<i>S</i>)-22,25,26-trihydroxy-22-oxido-16-oxo-17,21,23-trioxa-22\u03bb<small><sup>5</small></sup>-phosphahexacosan-19-yl (9<i>Z</i>)-octadec-9-enoate","metabolite_id":"PAZGBAOHGQRCBP-HGWHEPCSSA-N","pvalue":0.0009260520421532,"ratio":0.0704515706806282,"synonym_name":"16:0/18:1 PG"},{"chebi_id":"85037","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-[(11<i>Z</i>)-octadec-11-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"AEPVLLKGEBHLEJ-KWNHIAGJSA-N","pvalue":0.0020909946396532,"ratio":0.2273086029992107,"synonym_name":"1-Palmitoyl-2-vaccenoyl-sn-glycero-3-phosphocholine"},{"chebi_id":"73205","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-({[(2<i>S</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-2-(hexadecanoyloxy)propyl hexadecanoate","metabolite_id":"BIABMEZBCHDPBV-MPQUPPDSSA-N","pvalue":0.000714820519804,"ratio":0.3197781885397412,"synonym_name":"dihexadecanoylphosphatidylglycerol"},{"chebi_id":"89071","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VWDLPQNBLHJJIU-OILVUHFKSA-N","pvalue":0.045187813600112,"ratio":1.548141086749285,"synonym_name":"Phosphatidylglycerol(16:1n7/20:3n9)"}],"totalFeatures":15}